Search Results - "Verdorfer, I"

Refine Results
  1. 1

    EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder by Brunner, A, Prelog, M, Verdorfer, I, Tzankov, A, Mikuz, G, Ensinger, C

    Published in Journal of clinical pathology (01-03-2008)
    “…EpCAM is an adhesion molecule of the basolateral membranes in a variety of epithelial cells. Over-expression has been detected in many epithelial tumours and…”
    Get more information
    Journal Article
  2. 2

    Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer by BRUNNER, A, ENSINGER, C, CHRISTIANSEN, M, HEISS, S, VERDORFER, I, MIKUZ, G, TZANKOV, A

    “…Tetranectin (TN) is a plasminogen kringle-4 binding protein that can be detected in the plasma and the extracellular matrix. In malignancies, TN is thought to…”
    Get full text
    Journal Article
  3. 3

    Genetics of testicular germ cell tumors by Verdorfer, I

    Published in Der Pathologe (01-05-2014)
    “…Testicular cancer is by far the most common neoplasm among young males between the ages of 20 and 40 years and with an increasing incidence rate worldwide…”
    Get full text
    Journal Article
  4. 4

    Sertoli-Leydig cell tumours of the ovary and testis : a CGH and FISH study by VERDORFER, I, HORST, D, HÖLLRIGL, A, ROGATSCH, H, MIKUZ, G

    “…We present two malignant cases of Sertoli-Leydig cell tumours (SLCT) of the testis and one ovarian SLCT with benign behaviour. The DNA copy number changes…”
    Get full text
    Journal Article
  5. 5

    Molecular-cytogenetic characterisation of sex cord-stromal tumours : CGH analysis in sertoli cell tumours of the testis by VERDORFER, I, HÖLLRIGL, A, STRASSER, U, SUSANI, M, HARTMANN, A, ROGATSCH, H, MIKUZ, G

    “…Sertoli cell tumours (SCT) are rare and poorly explored neoplasias, and the genetic features of these uncommon tumours are largely unknown. Data about…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Leydig cell tumors of the testis : A molecular-cytogenetic study based on a large series of patients by VERDORFER, I, HORST, D, HOLLRIGL, A, SUSANI, M, HARTMANN, A, ROGATSCH, H, MIKUZ, G

    Published in Oncology reports (01-03-2007)
    “…The genetic features of the uncommon Leydig cell tumors (LCT) are largely unknown. Consequently, it is of great importance to elucidate the pathogenesis of…”
    Get full text
    Journal Article
  8. 8

    Comparative analysis of imbalances in genomic DNA and mRNA expression levels in chondrosarcoma-derived cell line FSCP-1 by Schörle, C M, Verdorfer, I, Finger, F, Block, J, Gebhart, E, Aigner, T

    Published in International journal of oncology (01-12-2004)
    “…Malignant cell transformation results from multiple biological alterations including chromosomal abnormalities, oncogene activation, loss of suppressor gene…”
    Get more information
    Journal Article
  9. 9

    Chromosome painting for cytogenetic monitoring of occupationally exposed and non-exposed groups of human individuals by Verdorfer, I., Neubauer, S., Letzel, S., Angerer, J., Arutyunyan, R., Martus, P., Wucherer, M., Gebhart, E.

    Published in Mutation research (05-04-2001)
    “…The suitability of a three-color fluorescence in situ suppression hybridization technique was examined for monitoring five different groups of individuals: 30…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Delimiting the use of comparative genomic hybridization in human myeloid neoplastic disorders by Gebhart, E, Verdorfer, I, Saul, W, Trautmann, U, Brecevic, L

    Published in International journal of oncology (01-06-2000)
    “…Hematopoietic disorders can be used as a suitable tool of additional information on the actual resolving power of comparative genomic hybridization (CGH)…”
    Get more information
    Journal Article
  12. 12

    I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC) by Bayerlein, K, Rith, T, Verdorfer, I, Liehr, T, Wolff, E, Girod, S, Gebhart, E

    Published in Anticancer research (01-01-2000)
    “…Interphase fluorescence in situ hybridization (I-FISH) was used to control the gain of genomic material in 21 human oral squamous cell carcinomas (OSCC) which…”
    Get more information
    Journal Article
  13. 13

    The cytogenetic view of standard comparative genomic hybridization (CGH): deletions of 20q in human leukemia as a measure of the sensitivity of the technique by Brecevic, L, Verdorfer, I, Saul, W, Trautmann, U, Gebhart, E

    Published in Anticancer research (01-01-2001)
    “…The limits of the resolving power of comparative genomic hybridization (CGH) have been given as 10-20 Mbp if at least 50% of the studied neoplastic cell…”
    Get more information
    Journal Article
  14. 14

    Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridization by Verdorfer, I, Hobisch, A, Culig, Z, Hittmair, A, Bartsch, G, Erdel, M, Duba, H C, Utermann, G

    Published in International journal of oncology (01-12-2001)
    “…Conventional cytogenetic analysis of prostatic carcinoma (PC) is characterized by inefficient growth of tumor cells during in vitro culture, leading to a lack…”
    Get more information
    Journal Article
  15. 15

    Thin section arrays for I-FISH analysis of chromosome-specific imbalances in squamous cell carcinomas of the head and neck by Ott, C E, Skroch, E, Steinhart, H, Verdorfer, I, Pahl, S, Iro, H, Gebhart, E, Bohlender, J E

    Published in International journal of oncology (01-03-2002)
    “…Thin section arrays of 20 head and neck squamous cell carcinomas were studied by I-FISH for gains (including amplification) and losses of specific genomic…”
    Get more information
    Journal Article
  16. 16

    MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas by Hannesdottir, L, Daschil, N, Philipp, S, Tymoszuk, P, Mueller-Holzner, E, Klima, G, Verdorfer, I, Doppler, W

    “…Signal transducer and activator of transcription 1 (STAT1) serves in the protection of the organism against pathogens and other harmful insults. It is…”
    Get full text
    Journal Article
  17. 17

    Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer by Brunner, A, Mayerl, C, Tzankov, A, Verdorfer, I, Tschörner, I, Rogatsch, H, Mikuz, G

    Published in Journal of clinical pathology (01-09-2004)
    “…Aims: Tenascin-C (Tn-C) is an extracellular matrix glycoprotein that is upregulated in malignant tumours. Tn-C promotes cell growth, cell migration, and…”
    Get full text
    Journal Article
  18. 18

    Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland by Verdorfer, Irmgard, Fehr, Andre, Bullerdiek, Jörn, Scholz, Nina, Brunner, Andrea, Krugmann, Jens, Hager, Martina, Haufe, Heike, Mikuz, Gregor, Scholtz, Arne

    Published in Oncology reports (01-08-2009)
    “…The aim of this study was to determine genetic alterations in mucoepidermoid carcinomas of the salivary gland in association with clinical and…”
    Get full text
    Journal Article
  19. 19

    Genetik der testikulären Keimzelltumoren by Verdorfer, I.

    Published in Der Pathologe (01-05-2014)
    “…Zusammenfassung Hodenkrebs ist mit Abstand die häufigste Neoplasie bei jungen Männern zwischen dem 20. und 40. Lebensjahr mit weltweit steigender Inzidenz. Als…”
    Get full text
    Journal Article
  20. 20